Skip to main content
. 2015 Dec 23;351:h6544. doi: 10.1136/bmj.h6544

Table 6.

Details on adverse events, intention to treat population of women with uncomplicated urinary tract infection randomised to ibuprofen or fosfomycin

Classification* Ibuprofen (n=241) Fosfomycin (n=243)
Certain infections and parasitic diseases—such as unspecified viral infection, worms 3 0
Diseases of blood and blood forming organs—such as anaemia 1
Endocrine, nutritional and metabolic diseases—such as goitre 1
Mental and behavioural disorders—such as grief, psychosomatic disorders 2 3
Diseases of the nervous system—such as headache, migraine 3 2
Diseases of the genitourinary system—such as vaginal thrush, local infection 3 1
Diseases of eye and ear—such as unspecific eye lid swelling, otitis, tinnitus 3 5
Diseases of circulatory system—such as hypertonia 1
Diseases of respiratory system—such as upper/lower respiratory infections, asthma 13 12
Diseases of digestive system—such as, nausea, diarrhoea, abdominal pain, vomiting 6 15
Diseases of skin—such as allergy, rash, naevi, eczema, photodermatosis 3 4
Diseases of musculoskeletal system—such as back pain, shoulder syndrome, cervical syndrome 12 14
Injuries and other external causes—such as fall, insect bites 1 4
Symptoms not elsewhere classified—such as abnormal transpiration, non-specific symptoms 1 2
Total No of adverse events 51 64

*Classification corresponds to international statistical classification of diseases and related health problems (ICD).

HHS Vulnerability Disclosure